Baker Bros. Advisors LP Fulgent Genetics, Inc. Transaction History

Baker Bros. Advisors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$37.92 - $63.74 $1.32 Million - $2.22 Million	-34,825 Reduced 17.29%	166,619 $6.35 Million
Q4 2021 Feb 14, 2022	SELL	$77.3 - $105.0 $15.4 Million - $21 Million	-199,572 Reduced 49.77%	201,444 $20.3 Million
Q1 2021 May 17, 2021	SELL	$59.3 - $183.85 $5.61 Million - $17.4 Million	-94,557 Reduced 19.08%	401,016 $38.7 Million
Q4 2020 Feb 16, 2021	SELL	$31.01 - $52.1 $1.57 Million - $2.64 Million	-50,616 Reduced 9.27%	495,573 $25.8 Million
Q3 2020 Nov 16, 2020	SELL	$15.89 - $50.51 $369,521 - $1.17 Million	-23,255 Reduced 4.08%	546,189 $21.9 Million
Q4 2019 Feb 14, 2020	BUY	$9.29 - $15.82 $4.13 Million - $7.03 Million	444,444 Added 355.56%	569,444 $7.35 Million
Q3 2017 Nov 14, 2017	BUY	$4.57 - $6.39 $571,250 - $798,750	125,000	125,000 $599,000

200

16M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $513M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Baker Bros. Advisors LP with notifications on news.